Trial Update

A talking point for the CANTOS trial
Trial Update

A talking point for the CANTOS trial

A year after the results of the CANTOS trial were first presented, they were still an important talking point at ESC Congress 2018 in Munich. They have established inflammation as another risk factor in atherosclerosis along with cholesterol.

Read More
Lessons from the CATCH study: beware of the risk of bleeding in neoplastic patients treated for VTE
Trial Update

Lessons from the CATCH study: beware of the risk of bleeding in neoplastic patients treated for VTE

The results of an interesting secondary analysis of the CATCH study were published recently and they are useful for a better understanding of the expectations and risks associated with the use of anticoagulants for the treatment of VTE in cancer patients.

Read More
CAT Studies
Trial Update

CAT Studies

A selection of the clinical trials about CAT.

Read More
Trial updates In thromboprophylaxis of cancer-related venous thromboembolism
Trial Update

Trial updates In thromboprophylaxis of cancer-related venous thromboembolism

The past decade has seen a large number of studies focusing on identifying cancer patients at high risk for venous thromboembolism (VTE).

Read More
New studies in prevention and treatment of cancer-associated thrombosis
Trial Update

New studies in prevention and treatment of cancer-associated thrombosis

The landmark CLOT Study changed practice by demonstrating that dalteparin monotherapy was more effective than LMWH followed by warfarin in treatment of VTE for up to 6 months in patients with cancer...

Read More